Your browser doesn't support javascript.
loading
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial.
Bartlett, Nancy L; Costello, Brian A; LaPlant, Betsy R; Ansell, Stephen M; Kuruvilla, John G; Reeder, Craig B; Thye, Lim S; Anderson, Daniel M; Krysiak, Kilannin; Ramirez, Cody; Qi, Jing; Siegel, Barry A; Griffith, Malachi; Griffith, Obi L; Gomez, Felicia; Fehniger, Todd A.
Afiliación
  • Bartlett NL; Division of Oncology and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
  • Costello BA; Mayo Clinic, Rochester, MN.
  • LaPlant BR; Mayo Clinic, Rochester, MN.
  • Ansell SM; Mayo Clinic, Rochester, MN.
  • Kuruvilla JG; University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Reeder CB; Mayo Clinic Arizona, Phoenix, AZ.
  • Thye LS; National Cancer Center Singapore, Singapore.
  • Anderson DM; Office of Education, Duke-National University of Singapore Graduate Medical School, Singapore.
  • Krysiak K; Metro-Minnesota Community Clinical Oncology Program, St. Louis Park, MN.
  • Ramirez C; Division of Oncology and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
  • Qi J; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; and.
  • Siegel BA; Division of Oncology and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
  • Griffith M; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; and.
  • Griffith OL; Division of Nuclear Medicine and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
  • Gomez F; Division of Nuclear Medicine and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
  • Fehniger TA; Division of Oncology and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
Blood ; 131(2): 182-190, 2018 01 11.
Article en En | MEDLINE | ID: mdl-29074501

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Linfoma Folicular / Inhibidores de Proteínas Quinasas / Agammaglobulinemia Tirosina Quinasa / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2018 Tipo del documento: Article País de afiliación: Macao

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Linfoma Folicular / Inhibidores de Proteínas Quinasas / Agammaglobulinemia Tirosina Quinasa / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2018 Tipo del documento: Article País de afiliación: Macao